16-alpha-hydroxylation of dehydroepiandrosterone by human fetal tissues. 1967

T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D002247 Carbon Isotopes Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope. Carbon Isotope,Isotope, Carbon,Isotopes, Carbon
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000311 Adrenal Glands A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS. Adrenal Gland,Gland, Adrenal,Glands, Adrenal
D001189 Aryl Hydrocarbon Hydroxylases A large group of cytochrome P-450 (heme-thiolate) monooxygenases that complex with NAD(P)H-FLAVIN OXIDOREDUCTASE in numerous mixed-function oxidations of aromatic compounds. They catalyze hydroxylation of a broad spectrum of substrates and are important in the metabolism of steroids, drugs, and toxins such as PHENOBARBITAL, carcinogens, and insecticides. Microsomal Monooxygenases,Xenobiotic Monooxygenases,Hydroxylases, Aryl Hydrocarbon,Monooxygenases, Microsomal,Monooxygenases, Xenobiotic
D065727 Cytochrome P-450 CYP2C8 A liver microsomal cytochrome P450 hydroxylase that oxidizes a broad spectrum of substrates including STEROIDS, FATTY ACIDS, and XENOBIOTICS. Examples of pharmaceutical substrates for CYP2C8 include; PACLITAXOL; torsemide; and; AMODIAQUINE CYP2C8,CYPIIC8,Cytochrome P450 MP-20,Cytochrome P450, Family 2, Subfamily C, Polypeptide 8,S-Mephenytoin 4-Hydroxylase,4-Hydroxylase, S-Mephenytoin,CYP2C8, Cytochrome P-450,Cytochrome P 450 CYP2C8,Cytochrome P450 MP 20,P-450 CYP2C8, Cytochrome,P450 MP-20, Cytochrome,S Mephenytoin 4 Hydroxylase
D065729 Cytochrome P-450 CYP2C9 A cytochrome P-450 subtype that has specificity for acidic XENOBIOTICS. It oxidizes a broad range of important clinical drugs that fall under the categories of NONSTEROIDAL ANTI-INFLAMMATORY AGENTS; HYPOGLYCEMIC AGENTS; ANTCOAGULANTS; and DIURETICS. CYP2C9,CYPIIC9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,CYP2C9, Cytochrome P-450,Cytochrome P 450 CYP2C9,Cytochrome P450 MP 4,Cytochrome P450 MP 8,Cytochrome P450 PB 1,MP-4, Cytochrome P450,MP-8, Cytochrome P450,P-450 CYP2C9, Cytochrome,P450 MP-4, Cytochrome,P450 MP-8, Cytochrome,P450 PB-1, Cytochrome,PB-1, Cytochrome P450

Related Publications

T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi
June 1968, Endocrinologia japonica,
T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi
March 1966, Steroids,
T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi
August 1986, The Journal of clinical endocrinology and metabolism,
T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi
August 1986, Clinical pharmacology and therapeutics,
T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi
December 1963, Experientia,
T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi
August 1961, Endocrinology,
T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi
January 1994, The Journal of clinical endocrinology and metabolism,
T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi
July 1966, Steroids,
T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi
February 1974, Nihon Naibunpi Gakkai zasshi,
T Nakayama, and K Arai, and K Sato, and T Yanaihara, and K Nagatomi
September 1965, Die Naturwissenschaften,
Copied contents to your clipboard!